key: cord-0761334-gz1srbfo authors: Barker, Piers C.A.; Lewin, Mark B.; Donofrio, Mary T.; Altman, Carolyn A.; Ensing, Gregory J.; Arya, Bhawna; Swaminathan, Madhav title: Specific Considerations for Pediatric, Fetal, and Congenital Heart Disease Patients and Echocardiography Service Providers During the 2019 Novel Coronavirus Outbreak: Council on Pediatric and Congenital Heart Disease Supplement to the Statement of the American Society of Echocardiography Endorsed by date: 2020-04-09 journal: J Am Soc Echocardiogr DOI: 10.1016/j.echo.2020.04.005 sha: 51699a4175d6da9789b3d2c9e1e400a6714773ec doc_id: 761334 cord_uid: gz1srbfo nan and their institutional recommendations regarding best practices to protect their patients and themselves. These reports are made available by ASE as a courtesy reference source for its members. The reports contain recommendations only and should not be used as the sole basis to make medical practice decisions or for disciplinary action against any employee. The statements and recommendations contained in these reports are primarily based on the opinions of experts, rather than on scientifically-verified data. ASE makes no express or implied warranties regarding the completeness or accuracy of the information in these reports, including the warranty of merchantability or fitness for a particular purpose. In no event shall ASE be liable to you, your patients, or any other third parties for any decision made or action taken by you or such other parties in reliance on this information. Nor does your use of this information constitute the offering of medical advice by ASE or create any physician-patient relationship between ASE and your patients or anyone else. The American Society of Echocardiography has recently released a statement on the "Protection of Patients and Echocardiography Service Providers During the 2019 Novel Coronavirus Outbreak" which will be continually updated as more data become available. 1 The pediatric and congenital heart disease (PCHD) population adds a confounding variable to this pandemic, which this supplement to the main statement 1 means to address. Readers are recommended to review the main statement; 1 this supplement will discuss how the PCHD population is different from the adult population, including transmission risk and indications for echocardiography; variations in protocols; and recommendations for fetal echocardiography and transesophageal echocardiography (TEE) for the PCHD population. Although children as an entire group appear to be at lower risk for severe disease compared to adults, certain ages are more susceptible to severe disease than others (particularly infants and pre-school aged children, and possibly premature infants). 2 The overall lower prevalence of severe disease paradoxically means that a large number of infected children may be asymptomatic or minimally symptomatic. 2, 3 When combined with the high viral loads present in nasopharyngeal and fecal secretions, 4,5 frequency of other upper respiratory tract viral coinfections, 3 necessity of adults accompanying children to medical care, and limited capabilities to avoid droplet expression in infants and toddlers, echocardiographic scanning of children may create an increased risk of staff and community exposure. Consequently, PCHD echocardiography providers will be exposed to SARS-CoV-2, perhaps often unknowingly, requiring adjustments in practice to provide expert care and limit further community transmission. Indications for the use of echocardiography in the PCHD population also differ from the adult population. 6 For PCHD patients, echocardiography will remain critical for the assessment of children with suspected heart disease, management of children and young adults with acquired and congenital heart disease at different stages of repair, palliation or transplant, and children at risk of functional heart disease (e.g. receiving chemotherapy) or cardiac complications from respiratory infection. Fetal and transesophageal echocardiography represent important clinical scenarios requiring variations in management. Pregnancies will continue and fetal heart disease remains critical to diagnosis and manage, albeit while reducing risk for infection of the mother or provider. Avoidance of provider transmission to the premature infant population with lung disease of different etiologies is similarly critical. The increased possibility that children may be infected with no or minimal symptoms may limit the utility of adult-focused screening measures. This may then necessitate adjustments to both inpatient and outpatient procedures such as designating which studies should be performed as portable studies, or designation of specific echo lab scan rooms or outpatient clinic sites. Given the higher risk of asymptomatic transmission in children, some centers in endemic regions are also choosing to test all new pediatric admissions for SARS-CoV-2. For institutions where fetal imaging occurs within the cardiology clinic, consideration should be given for pregnant women to be sequestered in a separate area from the pediatric patients, both in the waiting room and echo lab. Unlike previous viral outbreaks (H1N1, SARS-CoV, MERS-CoV) which were found to be associated with severe complications in pregnant women, currently the limited information available suggests that pregnant women are not more susceptible to SARS-CoV-2 infection or more prone to developing severe complications if infected. 10 Given the uncertainty and possibility of increased risk as more data become available, the CDC cautions that it is always important for pregnant women to protect themselves from illnesses, though the current recommendation is for them to follow the same precautions as the general public to avoid infection. For fetal cardiology visits, a maximum of one support person who undergoes the same screening process as the patients may accompany visits can be consolidated to include routine obstetrical care. Home fetal heart rate monitoring with telemedicine consultation instead of intermittent fetal echocardiography can also be considered in cases of fetal arrhythmia to minimize follow-up clinic visits. Infants or children presenting with known or suspected congenital heart disease, cardiomyopathy or myocarditis may have intercurrent respiratory illnesses and thus may be under suspicion for SARS-CoV-2 infection. This will require modification of PCHD imaging protocols away from "complete" studies and towards more focused exams. However, the breadth of congenital heart disease, and the challenges of systolic and diastolic function assessment in the PCHD population mean that unless the patient is in immediate need of assessment of only systolic function or pericardial effusion, "traditional" TTE by cardiology (pediatric or ACHD) is preferred over point of care ultrasound (POCUS) in the pediatric emergency center or intensive care unit. If a POCUS exam is performed, images should be saved and archived in a manner that allows review and remote interpretive assistance from experienced pediatric echocardiographers as well as comparison of cardiac structure and function over time. Review of POCUS studies may also help focus future imaging studies. Additional recommendations for focusing exams, particularly in patients with suspected or confirmed COVID-19, are presented in the main statement. 1 These include the use of live feeds and/or remote feedback to limit personnel in the patient room, and matching of sonographer skill to study indication to maximize diagnostic accuracy while minimizing scan time. As for adult patients, scans should be reviewed, and results recorded and communicated to the ordering team as quickly as possible to facilitate care. ASEcho.org For fetal echocardiographic studies, a complete study should be performed for all new consultations in order to minimize the need for repeat studies. Centers should have well-defined study protocols and checklists available as the study is being performed and as it is reviewed prior to the pregnant woman leaving the exam room. For follow-up scans deemed necessary, a focused study based on a predetermined checklist provided by the fetal cardiologist may be utilized. Prolonged scanning should be avoided. Transvaginal fetal echocardiographic studies should not be performed. Imaging of the pediatric patient with possible or confirmed COVID-19 differs from imaging of the adult in several ways. Children may frequently be asymptomatic or minimally symptomatic, which may unknowingly expose the provider to infection. Children are often unable to cooperate and follow instructions; cardiac anatomy may be highly variable and require longer scan times to assess; and sedation may be necessary for even routine transthoracic studies. Thus protection procedures require modification to those recommended for general adult echocardiography as presented in the main statement. 1 These PCHD modifications are presented below. Additional information regarding the role of learners, options for echocardiography education in the absence of direct scanning, and important general considerations for reducing transmission outside of the scan room are presented in the main statement. 1 Personnel As for the adult patient, imaging should be performed according to local standards for the prevention of virus spread, including use of Personal Protective Equipment (PPE). Meticulous ASEcho.org and frequent hand washing is crucial and applies to the sonographer, patient when possible, and to a single caregiver who is likely to contact patient and sonographer while helping to facilitate the cooperation of an active child. A surgical face mask should be worn by symptomatic patients, provided appropriate pediatric and adult-sized masks are available and institutional resources allow this strategy for source control. 11 In addition to the aerosolized transmission of SARS-CoV-2, potential for fecal transmission has been reported. 5, 12 Diaper care should therefore be avoided if possible during the exam, and if necessary performed with appropriate virucidal hygiene. The performance and interpretation of pediatric and fetal echocardiographic studies, especially those in suspected or confirmed COVID-19 cases, should be limited to essential personnel. Potentially complicated exams should be directed to experienced sonographers who are most likely to be able to perform an appropriately detailed, accurate, and expeditious exam without the need for additional hands-on support. In many institutions, PCHD fellows provide crucial offhours scanning and interpretation, but their skill level should be matched to patient complexity with availability of additional imager expertise when an expeditious exam cannot be obtained. In addition to limiting the number of echocardiography practitioners involved in scanning, consideration should be given to limiting the exposure of staff who may be particularly susceptible to severe complications of COVID-19. Staff who are >60 years old, have chronic conditions, are immunocompromised or are pregnant may wish to avoid contact with patients suspected or confirmed to have COVID-19, depending on local procedures. For intraoperative TEE, which is an essential contributor to the effective surgical treatment of congenital heart disease, strong consideration should be given to requesting that the ASEcho.org anesthesiologist place the TEE probe immediately after airway intubation while using appropriate aerosol precautions. Probe removal should be performed while under deep general anesthesia while intubated, with the probe immediately cleaned and then placed in a transport container for disinfection. There should be at most one person to handle the probe and another to operate the machine controls, along with another to administer anesthesia or sedation. Many Advanced Imaging: Fetal echocardiography and the care of pregnant women require a separate triaging system, which can be divided into three subgroups (Table and Figure 1 ). • Fetal echocardiogram for low risk patients: if a detailed second trimester fetal anatomic scan including adequate cardiac screening views can be confirmed by combined experience of practitioners (fetal cardiologist with Maternal-Fetal Medicine specialist/Obstetrician), no fetal echocardiographic evaluation is scheduled. • Fetal echocardiogram for moderate risk patients: delay fetal echocardiography evaluation to a later date when SARS-CoV-2 risk is decreased or after 28 weeks gestation (or earlier in specific situations, described in more detail below). • Fetal echocardiogram for high risk patients or urgent clinical indications: schedule and perform promptly (though consider alternatives such as lowest risk facility for imaging and telemedicine for consultation to minimize risk). This triage system requires close communication with the referring Obstetrical and Maternal-Fetal Medicine teams; noting that the recommended algorithms presented are not evidence-based but do represent shared perceived best practices and can be modified by each institution to best match local resources. Once it is decided that a Fetal Cardiology visit is needed, the timing of the Fetal Cardiology visit is based on multiple factors: 1) the risk profile of the indication (see Table) ; 2) the adequacy of the anatomy scan with cardiac views (determined by local collaborative experience of the referring doctor and fetal cardiologist, or if needed, direct review ASEcho.org of the cardiac screen, or discussion with the referring doctor); 3) the gestational age of the fetus which influences both pregnancy decision-making and need for additional testing (e.g. amniocentesis, ultrasound, MRI, gestational age < 24 weeks) and delivery planning for fetal CHD (gestational age ≥ 34 weeks). For those deferred to a later date, creation of a virtual "waiting list" should be considered for scheduling to assure that all patients at risk are evaluated prior to delivery. Fetal cardiovascular diseases requiring transplacental therapy (e.g. fetal tachyarrhythmia or autoimmune-mediated evolving congenital heart block) should be considered urgent indications for echocardiography and consultation, and scheduling and evaluating these patients should follow the admitting institutions COVID-19 policies for urgent admissions. Performance of fetal cardiac interventions (i.e. balloon aortic or pulmonary valvuloplasty, atrial septal stenting) remains at the discretion of the institution, though given the current body of evidence on risk-benefit ratio, delaying or not doing the procedure may be considered. The Transesophageal echocardiography carries a heightened risk of spread of SARS-CoV-2 since aerosolization of virus may be provoked during the procedure. This is of particular concern if the TEE is performed without concomitant endotracheal intubation, due to the coughing or gagging that may accompany probe placement and manipulation. However, aerosolization and provider exposure may be possible even with an endotracheal tube in place due to the instrumentation and manipulation of the oropharynx that occurs with TEE probe placement. TEEs therefore deserve special consideration in determining when and whether they should be The provision of echocardiographic services to the PCHD population remains crucial during this SARS-CoV-2 outbreak. Differences between the adult and PCHD populations require modifications to prior practices. These PCHD modifications are summarized in Figure 3 . Working together with our adult Cardiology, Anesthesia, Maternal-Fetal Medicine and Pediatric colleagues, we can continue to provide high quality care while minimizing risk to ourselves, our patients and the public. Suggested algorithm for performing TEE during COVID-19 Outbreak ASE Statement on Protection of Patients and Echocardiography Service Providers During the 2019 Novel Coronavirus Outbreak Pediatric Patients With 2019 Coronavirus Disease in China COVID-19 in Children: Initial Characterization of the Pediatric Disease Clinical presentation and virological assessment of hospitalized cases of coronavirus disease 2019 in a travel-associated transmission cluster Evidence for gastrointestinal infection of SARS-CoV-2 COVID-19 and the cardiovascular system Resources 1. ASE COVID-19 resource page Connect@ASE COVID-19 discussion page American Institute for Ultrasound in Medicine (AIUM) guidelines for equipment disinfection Centers for Disease Control COVID-19 resource page Centers for Disease Control recommendations for infection prevention and control Centers for Disease Control visual guide for using personal protective equipment ISUOG Safety Committee Position Statement: Safe performance of obstetric and gynecological scans and equipment cleaning in the context of COVID-19 The Society for Maternal Fetal Medicine COVID-19 Ultrasound Practice Suggestions The authors reported no actual or potential conflicts of interest in relation to this document.